Fig. 2From: Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitisLog2 fold change with CHF6001 1600 μg BID vs. log2 fold change with CHF6001 800 μg BID. Equality line in red, fitted loess curve in blue. Only differentially expressed probe sets (pFDR< 0.05 for at least one dose) are presented. Abbreviation: BID, twice dailyBack to article page